Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Grade II Chondrosarcoma"'
Publikováno v:
Annals of Maxillofacial Surgery
Rationale: Chondrosarcoma, although being a rare entity in jaws, may turn fatal if left untreated or inadequately excised. Prognosis in terms of 5-year survival rate ranges from 90% for Grade I, 81% for Grade II and 43% for Grade III respectively. Pa
Autor:
Karthikeyan Subramanian, Bhagwant Rai Mittal, Rajender Kumar, Jaya Shukla, Nandita Kakkar, Venkata Subramanian Krishnaraju, Naresh K. Panda, Ashwani Sood
Publikováno v:
Nucl Med Mol Imaging
Chondrosarcoma is a cartilaginous tumor of mesenchymal origin. The histology and grade of the tumor determine the chances of relapse and survival. These tumors usually respond poorly to chemo-radiotherapy in cases of non-resectable and recurrent dise
Autor:
Gitto, S., Cuocolo, R., Langevelde, K. van, Sande, M.A.J. van de, Parafioriti, A., Luzzati, A., Imbriaco, M., Sconfienza, L.M., Bloem, J.L.
Publikováno v:
EBioMedicine
EBioMedicine, Vol 75, Iss, Pp 103757-(2022)
EBioMedicine, 75. ELSEVIER
EBioMedicine, Vol 75, Iss, Pp 103757-(2022)
EBioMedicine, 75. ELSEVIER
Background:Atypical cartilaginous tumour (ACT) and grade II chondrosarcoma (CS2) of long bones are respectively managed with watchful waiting or curettage and wide resection. Preoperatively, imaging diagnosis can be challenging due to interobserver v
Autor:
Walid Ibn Essayed, Ossama Al-Mefty
Publikováno v:
Operative Neurosurgery. 21:E526-E527
Chondrosarcomas are a spectrum of tumors with variable clinical behavior, histologically classified as grades I, II, and III.1 Maximal surgical resection with adjuvant radiation is the gold standard for grade III malignant tumors.2,3 Lower-grade skul
Autor:
Asha Karadwal, Shailja Chatterjee
Publikováno v:
Journal of Oral and Maxillofacial Pathology : JOMFP
Chondrosarcoma is a rare malignant cartilaginous tumor of the head and neck region. It is a slow-growing tumor and is mostly detected in the anterior maxilla and the base of the skull. We report a case of "Grade II Chondrosarcoma" of the posterior ri
Publikováno v:
Clinical orthopaedics and related research. 477(3)
BACKGROUND: Although surgical resection or amputation has been the mainstay of localized chondrosarcoma management for many decades, its efficacy in patients with metastatic chondrosarcoma remains unknown, and likewise we do not know whether there ar
Publikováno v:
Medicine
Rationale: Localized chondrosarcoma of the scapula has a favorable long-term survival outcome. Therefore, recovery of shoulder function after surgery is important in middle-aged patients. Currently, three-dimensional (3-D) printing implants can be ap
Autor:
Danielle de Jong, José Antonio López-Guerrero, Silvia Calabuig-Fariñas, Amando Peydró, Antonio Pellín, Rosario Gil Benso, Lara Navarro, Karoly Szuhai, Isidro Machado, Antonio Llombart-Bosch, Teresa San Miguel
Publikováno v:
Pathology and Oncology Research, 18(4), 793-802
Chondrosarcomas are malignant cartilage-forming tumors that represent the third most common malignant solid tumor of bone. In patients with grades II and III, local recurrence, increasing tumor size and dedifferentiation have been associated with low
Publikováno v:
Neurologia medico-chirurgica. 50:502-505
A 60-year-old male was first treated for World Health Organization (WHO) grade II chondrosarcoma arising from the ring finger manifesting as painful swelling. Four years later, the patient presented with cerebral infarction. Echocardiography revealed
Publikováno v:
Veterinary and Comparative Orthopaedics and Traumatology. 23:273-276
SummaryThe clinical, radiographical and histo-pathological findings of a chondrosarcoma in the humerus of a goat are discussed. An 11-year-old female Saanen goat was admitted for evaluation of chronic, progressive left forelimb lameness. Clinical exa